✦ LIBER ✦

Dermal safety comparison of 0.05% desonide cream and 1.0% hydrocortisone cream

✍ Scribed by Roger C. Cornell; Michael D. Baker

Book ID: 117090488
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 220 KB
Volume: 53
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(05)80194-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled evaluation of 0.05% desonide

Controlled evaluation of 0.05% desonide lotion and desonide cream in psoriasis

✍ A. Greenspan; James H. Herndon Jr.; Michael D. Baker; Tricia Cheney 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Controlled, bilateral, comparative evalu

Controlled, bilateral, comparative evaluation of 0.05% desonide lotion and desonide cream in eczematous dermatitis

✍ S.E. Prawer; H.I. Katz; J.H. Herndon Jr.; M.D. Baker; T. Cheney 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Comparison of mometasone furoate 0.1% cr

Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis

✍ Vernon, Hazel J.; Lane, Alfred T.; Weston, William 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Comparison of adapalene cream 0.1% vs ta

Comparison of adapalene cream 0.1% vs tazarotene cream 0.05% in the treatment of acne and postinflammatory hyperpigmentation

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Efficacy and safety of hydrocortisone bu

Efficacy and safety of hydrocortisone buteprate 0.1% cream in patients with atopic dermatitis

✍ Howard W. Sears; Joseph W. Bailer; Arnold Yeadon 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 432 KB

0.25% Prednicarbate cream and the corres

0.25% Prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream

✍ H. C. Korting; D. Vieluf; M. Kerscher 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 301 KB

The atrophogenic potential of medium-potent topical glucocorticoids is still controversial. In a double-blind controlled trial 24 healthy volunteers either applied 0.25% prednicarbate cream or the corresponding vehicle to one and 0.1% betamethasone-17-valerate cream or 0.05% clobetasol-17-propionate